Sumithra J. Mandrekar

Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation

Richard M. Stone, Sumithra J. Mandrekar, Ben L. Sanford et al. · New England Journal of Medicine · 2017 · 2.1K citations · Full text

RECIST 1.1—Update and clarification: From the RECIST committee

Lawrence H. Schwartz, Saskia Litière, Elisabeth G.E. de Vries et al. · European Journal of Cancer · 2016 · 1.8K citations

Public Policy, Recist 1.1—Update, Law +2

Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL

Jennifer A. Woyach, Amy S. Ruppert, Nyla A. Heerema et al. · New England Journal of Medicine · 2018 · 927 citations · Full text

CT Screening for Lung Cancer: Five-year Prospective Experience

Stephen J. Swensen, James R. Jett, Thomas E. Hartman et al. · Radiology · 2005 · 637 citations

Clinical Trial Designs for Predictive Biomarker Validation: Theoretical Considerations and Practical Challenges

Sumithra J. Mandrekar, Daniel J. Sargent · Journal of Clinical Oncology · 2009 · 389 citations · Full text